Pricing Log in Create free account
Friday 6 November 2026 Export NEO’s income statement to Excel — free account

NeoGenomics, Inc.

NEO Healthcare Diagnostics & Research

NeoGenomics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $727.3 million, up 10.1% from fiscal 2024.

Revenue
+11.4%
EPS
+72.1%
Free cash flow
−3,724.2%
Total debt
+10.9%

Quarter to September 2026, against a year earlier

16.20 0.29 −1.76%
Market cap
$2.1B
P/E
0.0×
Fwd P/E
−68.4×
Dividend yield
—
F-score
4/9
Altman Z
1.79
Beneish M
−2.68
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

NeoGenomics, Inc. (NEO) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, NeoGenomics, Inc. (NEO) trades at a EV/Sales of 3.3×. Over the past ten years it has ranged from 1.4× (July 2025) to 14.4× (December 2020); the current reading is higher than 35% of that period. That is below the Diagnostics & Research industry median of 5.2× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.6× (23.43%)
FY2024 3.4× (5.78%)
FY2023 3.6× 48.82%
FY2022 2.4× (71.54%)
FY2021 8.5× (34.01%)
FY2020 12.9× 83.82%
FY2019 7.0× 64.98%
FY2018 4.2× 30.87%
FY2017 3.2× (0.71%)
FY2016 3.3× (37.22%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.6× 17.21%
Jun 2026 3.0× 66.97%
Mar 2026 1.8× (30.06%)
Dec 2025 2.6× 34.51%
43 more quarters

Against its own ten years

Low 1.4× High 14.4×
Ten-year median 3.6×
Current reading's percentile 34

EV/Sales against peers

Company EV/Sales
FRNM Freenome, Inc compare n/m
CSTL Castle Biosciences, Inc. compare 2.1×
VCYT Veracyte, Inc. compare 2.5×
OPK OPKO Health, Inc. compare 2.8×
NEO NeoGenomics, Inc. 3.3×
WGS GeneDx Holdings Corp. compare 4.2×
CDNA CareDx, Inc. compare 7.6×
ADPT Adaptive Biotechnologies Corporation compare 14.6×
PSNL Personalis, Inc. compare 18.6×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on NEO